Cristina Fornaguera Puigvert, PhD
Associate Professor
+34932672000
RESEARCH LINES
- Polymeric nanosystems for biomedical applications.
- Design of advanced drug delivery systems.
- Design of non-viral vectors for gene therapy.
- Optimisation of nanoformulations with organ-specific vectorisation.
- Formulation of mRNA vaccines based on nanosystems.
- Design of new immunotherapies for cancer treatment
MEMBER OF:
School of Engineering
Materials Engineering
Its activities focus on three main areas: the development of new functional materials, surface engineering and biomaterials.
School of Engineering
Chemical & Synthetic Biology for Biotherapies
This group combines chemistry and synthetic biology to develop precision bio-nano-therapeutics based on smart proteins and to generate molecular systems that enable transport of therapeutics to the brain.
LATEST PROJECTS
DemiRNApy (Role of miRNAs in the anterior cingulate cortex, as peripheral biomarkers, and their targeted modulation by nano-tools as a antidepressant therapy)
Role of microRNAs in the brain , as peripheral biomarkers and as nano-tools as novel antidepressant therapy
Funding Agency:
Research Group Link:
Materials Engineering (GEMAT)
Chemical & Synthetic Biology for Biotherapies (ChemSynBio)
TumorOut (Innovative mRNA vaccine against lung cancer)
Innovative platform of targeted polymeric nanoparticles for efficient personalized therapy against lung cancer
Funding Agency:
Research Group Link:
Materials Engineering (GEMAT)
Chemical & Synthetic Biology for Biotherapies (ChemSynBio)
ZwiRNA (Nanopartículas zwiteriónicas como vacunas de ARNm contra el cáncer pulmonar)
Desarrollo de Nanopartículas zwiteriónicas de Poli(beta-aminoester) como vacunas de mRNA para tratar el cáncer de pulmón de células no pequeñas (zwiRNA).
Funding Agency:
Research Group Link:
Materials Engineering (GEMAT)
Chemical & Synthetic Biology for Biotherapies (ChemSynBio)
LINKED NEWS
Doctoral thesis
Polymers for Invisible Nanoparticles in mRNA Vaccines
13/09/2023
Dr Coral García recently defended her doctoral thesis at IQS, in which she managed to develop a system of polymeric vaccines based on mRNA that are invisible to premature elimination by the immune system and ensure that they exclusively impact target cells.
READ FULL NEW
Research
New personalized therapeutic vaccine for lung cancer
07/03/2023
IQS professor Dr Cristina Fornaguera is leading the European project TumorOUT to design a new immunotherapy based on polymer nanoparticles with encapsulated antigenic mRNAs to holistically attack different mechanisms of lung cancer.
READ FULL NEW
Research
Micro RNAs to Treat Depression
09/01/2023
IQS is one of the members of the DemiRNApy project, one of the 36 research projects selected by the Fundació Marató TV3 charitable fundraising drive in its 2021 edition dedicated to mental health, with the aim of developing nanotherapies to treat depression.
READ FULL NEW
Research
Invisible, Targeted mRNA Vaccines
03/11/2022
The GEMAT group at IQS is working on the zwiRNA project with the goal of designing a new state-of-the-art therapeutic vaccine for the treatment of lung cancer.
READ FULL NEW
Interview
Interview with Dr José Rodrigo Magaña and Dr Cristina Fornaguera
10/06/2022
"My contribution to the ANTIEMT project is designing genetic material transporters. They are invisible polymers for most of the body's cells, except for tumor cells, to which they are targeted as ‘ninjas.’"
READ FULL NEW
News
Confocal Microscopy
05/02/2021
IQS has a Leica SP8 Confocal Scanning Microscope used for any application that involves the analysis of images that emit fluorescence, on their own or if they have been previously labeled with fluorophores, that allows the analysis of materials and biomaterials in addition to the analysis of biological tissues and cell culture.
READ FULL NEW
Interview
Dr Borrós and Dr Fornaguera, leaders of the CoviNanoVax project
08/01/2021
“We have our mRNA encapsulated, which appears from the outset that it will be immunogenic, stable and non-toxic, with stable nanoparticles at 4ºC, and obtained through an easily scalable process.“
READ FULL NEW
